Li Jinliang, Wang Lianqu, Zhang Jiule, Li Xiaoguang, Jiao Zhiling
Department of Urology, The First Affiliated Hospital of Henan University, 357 Ximen Street, Longting Kaifeng, Kaifeng Henan, 475000, China.
BMC Nephrol. 2025 Jul 1;26(1):310. doi: 10.1186/s12882-025-04212-1.
Stress hyperglycemia ratio (SHR) is a novel indicator used to evaluate the severity of SH. This study aimed to explore the association between SHR and the risk of AKI and death among individuals with chronic kidney disease (CKD).
This retrospective cohort investigation sourced data from the Medical Information Mart for Intensive Care-IV (MIMIC IV2.2) repository. The primary endpoint was AKI incidence, while secondary endpoints included in-hospital mortality and renal replacement therapy (RRT). The correlation of SHR with the likelihood of AKI in CKD patients was assessed utilizing restricted cubic spline (RCS) and Cox proportional hazards models. Then using Kaplan-Meier survival curves to analyze endpoint differences across varying SHR levels.
Among 2,500 CKD patients, 795 (31.8%) developed AKI during hospitalization. Cox proportional hazards analysis indicated a positive association between SHR and AKI incidence. The RCS model showed an approximately linear relationship, with higher SHR linked to increased AKI risk. In addition, Kaplan-Meier survival analysis unveiled notable distinctions in three endpoints across cohorts of patients characterized by varying SHR levels.
SHR emerges as a dependable and autonomous indicator for predicting AKI occurrence and unfavorable renal outcomes in individuals with CKD.
Not applicable.
应激性高血糖比率(SHR)是用于评估应激性高血糖严重程度的一项新指标。本研究旨在探讨SHR与慢性肾脏病(CKD)患者急性肾损伤(AKI)风险及死亡风险之间的关联。
这项回顾性队列研究的数据来源于重症监护医学信息数据库-IV(MIMIC IV 2.2)。主要终点是AKI发病率,次要终点包括院内死亡率和肾脏替代治疗(RRT)。利用受限立方样条(RCS)和Cox比例风险模型评估SHR与CKD患者发生AKI可能性的相关性。然后使用Kaplan-Meier生存曲线分析不同SHR水平下终点的差异。
在2500例CKD患者中,795例(31.8%)在住院期间发生了AKI。Cox比例风险分析表明SHR与AKI发病率呈正相关。RCS模型显示出近似线性关系,SHR越高,AKI风险越高。此外,Kaplan-Meier生存分析揭示了不同SHR水平患者队列在三个终点方面存在显著差异。
SHR是预测CKD患者发生AKI及不良肾脏结局的可靠且独立的指标。
不适用。